SAN DIEGO, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced it will participate in the Inflammatory Bowel Disease Symposium hosted virtually by Canaccord Genuity Capital Markets on Wednesday, February 28, 2024. Ariella Kelman, M.D., Chief Medical Officer, will participate in the panel titled "The Next Evolutionary Steps in Addressing IBD," beginning at 10:00 AM Eastern / 7:00 AM Pacific time. Interested pa ...